Investment in NovoDX, a Related Party (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Dec. 31, 2024 |
Sep. 24, 2024 |
Dec. 31, 2025 |
May 14, 2024 |
|
| Common stock shares outstanding | 13,110,000 | 14,761,925 | ||
| Loss on investments | $ 500,000 | |||
| Investments | $ 0 | |||
| Common Stock [Member] | Novo DX Corporation [Member] | ||||
| Restricted shares issued, price per share | $ 19.89 | |||
| Novo DX Corporation [Member] | ||||
| Common stock shares outstanding | 25,134 | |||
| Cost of investment | $ 500,000 | |||
| Fair value of investment | $ 500,000 |
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This element represents the aggregate cost of investments accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of investment in security owned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|